Hiroatsu Iida

2.2k total citations
83 papers, 1.4k citations indexed

About

Hiroatsu Iida is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Hiroatsu Iida has authored 83 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Hematology, 26 papers in Oncology and 21 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Hiroatsu Iida's work include Hematopoietic Stem Cell Transplantation (28 papers), Acute Myeloid Leukemia Research (21 papers) and Acute Lymphoblastic Leukemia research (20 papers). Hiroatsu Iida is often cited by papers focused on Hematopoietic Stem Cell Transplantation (28 papers), Acute Myeloid Leukemia Research (21 papers) and Acute Lymphoblastic Leukemia research (20 papers). Hiroatsu Iida collaborates with scholars based in Japan, United States and Greece. Hiroatsu Iida's co-authors include Hidehiko Saito, Masayuki Towatari, Mitsune Tanimoto, Koichi Miyamura, Tomoki Naoe, Ritsuro Suzuki, Hitoshi Kiyoi, Michinari Hamaguchi, Hiroji Iwata and Y Kodera and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Hiroatsu Iida

80 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroatsu Iida Japan 22 836 405 365 331 241 83 1.4k
Paul Shaughnessy United States 20 1.3k 1.6× 508 1.3× 274 0.8× 494 1.5× 213 0.9× 85 1.8k
Antonella Geromin Italy 21 641 0.8× 549 1.4× 316 0.9× 221 0.7× 157 0.7× 55 1.2k
Radovan Sašo United Kingdom 22 846 1.0× 384 0.9× 278 0.8× 311 0.9× 105 0.4× 50 1.2k
Hawk Kim South Korea 22 882 1.1× 443 1.1× 342 0.9× 226 0.7× 212 0.9× 111 1.5k
Yeo‐Kyeoung Kim South Korea 20 675 0.8× 261 0.6× 412 1.1× 243 0.7× 132 0.5× 91 1.2k
Athanasios Zomas Greece 18 852 1.0× 443 1.1× 502 1.4× 207 0.6× 180 0.7× 55 1.3k
Jin Takeuchi Japan 22 987 1.2× 390 1.0× 448 1.2× 211 0.6× 605 2.5× 94 1.7k
M. A. Boogaerts Belgium 20 823 1.0× 242 0.6× 266 0.7× 232 0.7× 135 0.6× 29 1.2k
Roberto Rondelli Italy 23 900 1.1× 341 0.8× 380 1.0× 321 1.0× 709 2.9× 73 1.8k
Yunsuk Choi South Korea 18 480 0.6× 444 1.1× 339 0.9× 136 0.4× 136 0.6× 101 1.1k

Countries citing papers authored by Hiroatsu Iida

Since Specialization
Citations

This map shows the geographic impact of Hiroatsu Iida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroatsu Iida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroatsu Iida more than expected).

Fields of papers citing papers by Hiroatsu Iida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroatsu Iida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroatsu Iida. The network helps show where Hiroatsu Iida may publish in the future.

Co-authorship network of co-authors of Hiroatsu Iida

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroatsu Iida. A scholar is included among the top collaborators of Hiroatsu Iida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroatsu Iida. Hiroatsu Iida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yokoyama, Hisayuki, Noriko Fukuhara, Koji Ando, et al.. (2025). Phase 1 study of rogocekib in patients with relapsed or refractory hematologic malignancies. Blood Advances. 10(1). 262–272.
4.
Inagaki, Yuichiro, Shohei Mizuno, Nobuhiro Nishio, et al.. (2023). Development of TCR-T cell therapy targeting mismatched HLA-DPB1 for relapsed leukemia after allogeneic transplantation. International Journal of Hematology. 118(2). 252–266. 1 indexed citations
5.
6.
Usuki, Kensuke, Hiroshi Handa, Ilseung Choi, et al.. (2019). Safety and pharmacokinetics of quizartinib in Japanese patients with relapsed or refractory acute myeloid leukemia in a phase 1 study. International Journal of Hematology. 110(6). 654–664. 17 indexed citations
7.
Sugiyama, Keiji, Yuta Hasegawa, Hiroyuki Nakamura, et al.. (2016). The efficacy and safety of re-administration of rasburicase for patients with hematological malignancies. Annals of Oncology. 27. vii100–vii100.
8.
Adachi, Takashi, et al.. (2015). Enlarging mediastinal/hilar lymphadenopathy with calcification. Clinical Case Reports. 4(2). 212–213. 5 indexed citations
10.
Imahashi, Nobuhiko, Ritsuro Suzuki, Takahiro Fukuda, et al.. (2012). Allogeneic hematopoietic stem cell transplantation for intermediate cytogenetic risk AML in first CR. Bone Marrow Transplantation. 48(1). 56–62. 12 indexed citations
11.
Inamoto, Yoshihiro, Koichi Miyamura, Shiki Okamoto, et al.. (2010). Disease stage stratified effects of cell dose in unrelated BMT for hematological malignancies: a report from Japan marrow donor program. Bone Marrow Transplantation. 46(9). 1192–1202. 3 indexed citations
12.
Nishiwaki, Satoshi, Seitaro Terakura, Takahiko Yasuda, et al.. (2010). Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission. International Journal of Hematology. 91(3). 419–425. 1 indexed citations
13.
Inamoto, Yoshihiro, Makoto Murata, Akira Katsumi, et al.. (2009). Donor single nucleotide polymorphism in the CCR9 gene affects the incidence of skin GVHD. Bone Marrow Transplantation. 45(2). 363–369. 21 indexed citations
14.
Narimatsu, Hiroto, Masaki Iino, Toshiya Yokozawa, et al.. (2008). Clinical significance of minimal residual disease in patients with t(8;21) acute myeloid leukemia in Japan. International Journal of Hematology. 88(2). 154–158. 7 indexed citations
15.
Sugimoto, Kyoko, Hiroto Narimatsu, Takakazu Kawase, et al.. (2008). Clinical characteristics of chronic graft-versus-host disease following umbilical cord blood transplantation for adults. Bone Marrow Transplantation. 41(8). 729–736. 4 indexed citations
16.
Atsuta, Yoshiko, Ritsuro Suzuki, Kazuhito Yamamoto, et al.. (2006). Risk and prognostic factors for Japanese patients with chronic graft-versus-host disease after bone marrow transplantation. Bone Marrow Transplantation. 37(3). 289–296. 22 indexed citations
18.
Shimada, Kazuyuki, Yoshiko Atsuta, A Kohno, et al.. (2005). Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis. Bone Marrow Transplantation. 36(2). 115–121. 55 indexed citations
19.
Iida, Hiroatsu, Masayuki Towatari, Minako Iida, et al.. (2000). Protein expression and constitutive phosphorylation of hematopoietic transcription factors PU.1 and C/EBP beta in acute myeloid leukemia blasts.. PubMed. 71(2). 153–8. 14 indexed citations
20.
Hayakawa, Fumihiko, Masayuki Towatari, Hiroatsu Iida, et al.. (1998). Differential constitutive activation between STAT‐related proteins and MAP kinase in primary acute myelogenous leukaemia. British Journal of Haematology. 101(3). 521–528. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026